Quest Diagnostics (DGX) Operating Leases (2019 - 2025)
Historic Operating Leases for Quest Diagnostics (DGX) over the last 7 years, with Q3 2025 value amounting to $534.0 million.
- Quest Diagnostics' Operating Leases fell 165.75% to $534.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $534.0 million, marking a year-over-year decrease of 165.75%. This contributed to the annual value of $535.0 million for FY2024, which is 1930.62% down from last year.
- According to the latest figures from Q3 2025, Quest Diagnostics' Operating Leases is $534.0 million, which was down 165.75% from $540.0 million recorded in Q2 2025.
- In the past 5 years, Quest Diagnostics' Operating Leases registered a high of $679.0 million during Q4 2021, and its lowest value of $489.0 million during Q1 2024.
- Its 5-year average for Operating Leases is $536.6 million, with a median of $508.0 million in 2023.
- In the last 5 years, Quest Diagnostics' Operating Leases soared by 2298.29% in 2021 and then crashed by 1930.62% in 2024.
- Quarter analysis of 5 years shows Quest Diagnostics' Operating Leases stood at $679.0 million in 2021, then fell by 4.12% to $651.0 million in 2022, then increased by 1.84% to $663.0 million in 2023, then dropped by 19.31% to $535.0 million in 2024, then dropped by 0.19% to $534.0 million in 2025.
- Its last three reported values are $534.0 million in Q3 2025, $540.0 million for Q2 2025, and $538.0 million during Q1 2025.